OZGUR SAHIN LAB

  • Home
  • Research Interests
  • Lab Members
  • Publications
  • Funding
  • Protocols
  • Open Positions
  • Contact
  • Lab Photos
  • Alumni

See the latest news about our lab!

Published by sahinozgur on July 22, 2024July 22, 2024

“Hollings team marks milestone in progress toward investigational new drug for triple-negative breast cancer”

https://hollingscancercenter.musc.edu/news/archive/2024/07/22/lox-inhibitor-for-triple-negative-breast-cancer

Categories: News

0 Comments

Leave a Reply Cancel reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

Related Posts

News

White Coat Ceremony: Welcoming Ana as Our New B.L.O.C.K.S. Scholar

Ana is one of only 10 undergraduate students selected from the College of Charleston for the B.L.O.C.K.S. (Building Learning Opportunities for Cancer, Knowledge, and Success) program. She will be gaining valuable experience and knowledge in Read more

News

Congratulations to Dr. Sahin on his new role as Program Director of Science Translation for the Hollings Advisory for Rapid Translation (HART).

Our PI, Dr. Ozgur Sahin, has accepted the position of Program Director of Science Translation for the Hollings Advisory for Rapid Translation (HART). In this newly created role, he will lead and support strategic initiatives Read more

News

Congrats Kubra!

PhD candidate Kubra was awarded the Hollings Fellowship for her research titled “Targeting Triple-Negative Breast Cancer with High Chromosomal Instability.”

Hestia | Developed by ThemeIsle